Skip to content

Author

Ying Lu

We have 2 of 27 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Longitudinal analysis of genomic and immune differences between primary and metastatic nasopharyngeal carcinoma for precision oncology

Primary tumors show an immunosuppressive phenotype, suggesting potential benefits from combining CTLA4 or IDO1 inhibitors with PD-1 blockade, and Liver metastases exhibit distinct immune features, supporting the need for site-specific precision therapies.

Ying Lu, T. Han, Li-Hui Wang et al. · 0 citations
Review Open access Jul 2026

Radiomics and clinical data predict pseudoprogression after radiotherapy in high-grade glioma

The integrated model showed acceptable internal validation performance and provided a clinically interpretable framework for individualized PsP risk estimation by combining radiomic, perfusion-diffusion, inflammatory, molecular, and treatment-related information.

Zhou Jiang, Danmeng Zhang, Hui Yang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.